🎧 Deep Dive: Immune Thrombocytopenia (ITP) 🩸🛡️
Ever wondered why someone bruises super easily or what “low platelets” on a blood test really means? This episode takes you on a clear, concise, and clinical journey through everything you need to know about Immune Thrombocytopenia (ITP) — a high-yield haematology topic for the MSRA and beyond.

🧠 In This Episode You’ll Learn:

✅ Definition & Overview
→ ITP = Autoimmune attack on platelets, causing thrombocytopenia and bleeding risk
→ Also known as Idiopathic Thrombocytopenic Purpura
→ Key distinction:
• Primary ITP = no clear trigger
• Secondary ITP = linked to infections, autoimmune disease, meds, malignancy

✅ Causes & Risk Factors
→ Autoantibodies attack and destroy platelets in spleen/liver
→ Linked to SLE, HIV, HCV, H. pylori, drugs, lymphoma
→ Risk ⬆️ with female sex (esp. 30–60), viral illness, possible family history

✅ Pathophysiology
→ Platelets are marked for destruction
→ Destruction in spleen + impaired bone marrow production
→ Result = low platelet count ➝ increased bleeding tendency

✅ Differential Diagnoses 🕵️‍♂️
→ Always rule out:
• TTP
• Drug-induced thrombocytopenia
• Leukaemia
• DIC, aPlastic anaemia, HUS, Alcohol misuse, SLE, von Willebrand’s disease

✅ Epidemiology
→ UK incidence ~3.3–5 per 100,000/year
→ Prevalence ~50 per 100,000
→ More common in females aged 30–60
→ Children = often post-viral + self-resolving
→ Adults = more likely chronic

✅ Symptoms & Clinical Presentation
→ Easy bruising
→ Petechiae (pinpoint dots), purpura (larger purple patches)
→ Nosebleeds, bleeding gums, menorrhagia
→ Often diagnosed incidentally on FBC
→ Severe bleeds like intracranial haemorrhage = rare but serious

✅ Investigations
→ 📊 Full blood count = isolated thrombocytopenia
→ 🔬 Blood smear = large platelets
→ 🧪 Rule out HIV, Hep C
→ Bone marrow biopsy if unclear or atypical
→ Antiplatelet antibody tests = available but not definitive

✅ Management
🟢 Mild/asymptomatic:
→ Watchful waiting
🔴 Moderate-severe:
→ Corticosteroids (first line)
→ IVIG for quick platelet boost
→ Second-line options:

• TPO receptor agonists (e.g. romiplostim, eltrombopag)

• Rituximab

• Splenectomy (for refractory cases)
  🔧 Also:
  → Stop platelet-affecting meds, control BP, manage menorrhagia

✅ Prognosis & Complications
→ ⭐ Children: Usually self-resolves
→ ⚠️ Adults: May be chronic, but prognosis generally good
→ 🔺 Complications:

• Bleeding (rarely severe)

• Rare progression to MDS/AML

• Infections from immunosuppressive treatments

• Treatment side effects (e.g. long-term steroids)

📚 Resources for MSRA Revision:

📝 ITP Revision Notes
https://www.passthemsra.com/topic/immune-thrombocytopenia-itp-revision-notes/

🃏 Flashcards
https://www.passthemsra.com/topic/immune-thrombocytopenia-itp-flashcards/

📖 Accordion Q&A Notes
https://www.passthemsra.com/topic/immune-thrombocytopenia-itp-accordion-qa-notes/

🧠 Rapid Fire Quiz
https://www.passthemsra.com/topic/immune-thrombocytopenia-itp-rapid-quiz/

🧪 Practice Quiz
https://www.passthemsra.com/quizzes/immune-thrombocytopenia-itp/

💭 Final Thought:
ITP reveals just how delicately balanced our immune system is — and what happens when that balance breaks down. Could other autoimmune conditions start the same way? And how can we better predict who will progress from acute to chronic disease?

#MSRA #ImmuneThrombocytopenia #ITP #MSRAFlashcards #MSRAQuiz #Haematology #AutoimmuneDiseases #MSRAQuestionBank #PassTheMSRA #BleedingDisorders #WatchfulWaiting #Corticosteroids #MSRAExamPrep #Platelets

🎧 MSRA Podcast: G6PD Deficiency – Exam-Ready Essentials & Rapid Revision 🎧

Crack G6PD Deficiency for the MSRA with this focused, high-yield revision episode. We slice through the noise and give you what matters—perfect for rapid review or your next commute.

🧬 Definition:
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common enzyme deficiency worldwide. It’s a genetic disorder (X-linked recessive) affecting red blood cells, making them prone to haemolysis under oxidative stress.

🦠 Causes / Risk Factors:

• Mutation in the G6PD gene on the X chromosome

• Highest prevalence in males, especially those of African, Mediterranean, or Asian descent

• Carriers (usually females) typically asymptomatic

• High global prevalence: ~400 million people

⚡ Pathophysiology:

• G6PD helps make NADPH, which keeps glutathione active

• Glutathione is the cell’s main antioxidant—deficiency leaves RBCs vulnerable to oxidative damage

• Haemolysis is usually triggered (not constant)

⚠️ Common Triggers:

• Drugs: Antimalarials (primaquine), quinolones (ciprofloxacin, etc.), sulfa drugs, nitrofurantoin, dapsone, methylene blue

• Infections: Any severe infection

• Foods: Fava beans (broad beans)

• Others: Diabetic ketoacidosis, acute kidney injury, mothballs (naphthalene)

🩺 Clinical Features:

• Most are asymptomatic until exposed to a trigger

• Acute haemolytic episode:

  • Fatigue, pallor, jaundice, dark (cola-coloured) urine, shortness of breath

  • Neonatal jaundice can be the first sign

  • Recurrent episodes can cause gallstones, splenomegaly

🔎 Diagnosis:

• G6PD enzyme activity assay (gold standard)

• FBC: Anaemia during crisis, raised reticulocyte count

• Blood film: "Bite cells", "blister cells", Heinz bodies (with special stain)

• Supporting labs: Raised unconjugated bilirubin, low haptoglobin, raised LDH

• Direct Coombs test negative (helps exclude autoimmune haemolysis)

🛡️ Management:

• Avoid triggers: Patient education is crucial

• Supportive care: Hydration, blood transfusions in severe cases

• Treat infections promptly

• Folic acid supplementation in chronic/recurrent cases

• Rare: Splenectomy for very severe, chronic cases

⏳ Prognosis:

• Excellent with avoidance of triggers and proper management

• Serious risks: Acute kidney injury and severe anaemia if untreated, kernicterus in newborns with uncontrolled jaundice

• Chronic complications: Gallstones, splenomegaly

🧠 Memory Aids:

• G6PDC:

  • Gender (males), 6 (enzyme), Precipitated by triggers, Drug and Diet triggers, Crises

• Compare with hereditary spherocytosis (HS):

  • G6PD: Males, African/Mediterranean, triggered crises, Heinz bodies

  • HS: Both genders, Northern European, chronic + crises, spherocytes

• 📖 Revision Notes:
https://www.passthemsra.com/topic/g6pd-deficiency-revision-notes/

• 🃏 Flashcards:
https://www.passthemsra.com/topic/g6pd-deficiency-flashcards/

• ❓ Accordion Q&A Notes:
https://www.passthemsra.com/topic/g6pd-deficiency-accordion-qa-notes/

• 🏆 Rapid Fire Quiz:
https://www.passthemsra.com/topic/g6pd-deficiency-rapid-quiz/

• 📝 Online Quiz:
https://www.passthemsra.com/quizzes/g6pd-deficiency/

#MSRA #G6PDDeficiency #Haematology #MSRARevision #MSRAQuiz #PassTheMSRA

Exam Pearl:
Always check drug histories and ask about family background in any unexplained haemolysis, especially in males of African, Mediterranean, or Asian ancestry.

🗝️ Key Learning Points🔗 G6PD Deficiency Revision Resources for the MSRA

🧬 FREE MSRA PODCAST – Acute Myeloid Leukaemia: Fast Facts & High-Yield Revision

In this high-yield deep dive, we simplify the essentials of Acute Myeloid Leukaemia (AML) for the MSRA exam. We’ll cover the definitions, classifications, causes, red-flag symptoms, investigations, treatment pathways, and key complications. 🎯

🧠 Key Learning Points

📌 Definition
AML = cancer of myeloid precursors in the bone marrow, leading to >20% blasts in marrow or blood. These abnormal cells multiply rapidly, suppressing normal cell production.

📌 Classification Systems
🔹 WHO Classification (modern, genetic-based)
– Recurrent genetic abnormalities (e.g. t(15;17) in APL)
– AML with myelodysplasia-related changes
– Therapy-related AML
– AML, NOS (not otherwise specified)
– Myeloid sarcoma, AML in Down’s syndrome

🔹 FAB Classification (M0–M7) – Mnemonics help:
M0: Minimal diff
M1: No maturation
M2: Granulocytic maturation
M3: APL (t(15;17), DIC risk, ATRA treatment)
M4: Myelomonocytic
M5: Monocytic (M5a = immature, M5b = mature)
M6: Erythroid (M6a = erythroleukaemia)
M7: Megakaryoblastic

📌 Causes & Risk Factors
• Often idiopathic, but core cause = genetic mutations
• Risk factors:
 – Prior chemo/radiation
 – Benzene exposure (esp. M6)
 – Smoking
 – Genetic syndromes: Down’s, Fanconi, Bloom
 – Pre-existing blood disorders (MDS, polycythaemia, aplastic anaemia)
 – Transformation from other leukaemias (e.g. CML blast crisis)

📌 Pathophysiology
• Uncontrolled proliferation of immature myeloid blasts
• Bone marrow fails → anaemia, thrombocytopenia, neutropenia
• Blasts infiltrate other organs (spleen, liver, CNS, gums)

📌 Clinical Features
🎯 Mnemonic: ABC of AML
A – Anaemia: fatigue, SOB, pallor
B – Bleeding: bruising, petechiae, nose/gum bleeds
C – Cytopenia: infections, fever
Other signs: bone pain, hepatosplenomegaly, gum hypertrophy, leukostasis (dyspnoea/confusion if high WCC)

🧠 APL (M3): DIC at presentation, t(15;17), treated with ATRA ± arsenic

📌 Investigations
• FBC: ↓ Hb, ↓ platelets, variable WCC, blasts on film
• Coagulation screen (especially in M3)
• Bone marrow biopsy = diagnostic (≥20% blasts)
• Flow cytometry (confirm lineage)
• Cytogenetics & molecular markers (e.g. FLT3, NPM1)
• CXR, ECG, ECHO before chemo
• Infection screen, LFTs, U&Es, LDH

📌 Management Overview
🎯 Mnemonic: I.C.T.S.
I – Induction chemo (e.g. cytarabine + daunorubicin)
C – Consolidation (chemo or stem cell transplant)
T – Targeted therapy (e.g. FLT3 inhibitors, ATRA for APL)
S – Supportive care: transfusions, antibiotics, tumour lysis prophylaxis

• Maintenance: NICE recommends oral azacitidine in some cases
• Stem cell transplant: Allo-SCT for high-risk or persistent disease
• APL: ATRA + arsenic trioxide (excellent prognosis if treated early)

📌 Prognosis & Survival
• Better if: young, good performance status, favourable cytogenetics
• Poorer with: age >60, FLT3-ITD, therapy-related AML, CNS involvement, complex cytogenetics
• 5-year survival:
 – Adults: ~17%
 – Children: 65–75%

📌 Complications
• Infection, bleeding, anaemia
• DIC (esp. in APL)
• Leukostasis
• Tumour lysis syndrome
• Long-term risks: secondary cancers, organ toxicity, psychological stress

📎 More MSRA Resources for AML

📝 Revision Notes:
https://www.passthemsra.com/topic/acute-myeloid-leukaemia-revision-notes/

🧠 Flashcards:
https://www.passthemsra.com/topic/acute-myeloid-leukaemia-flashcards/

💬 Accordion Q&A Notes:
https://www.passthemsra.com/topic/acute-myeloid-leukaemia-accordion-qa-notes/

🚀 Rapid Quiz:
https://www.passthemsra.com/topic/acute-myeloid-leukaemia-rapid-quiz/

🎓 Haematology Course:
https://www.passthemsra.com/courses/haematology-for-the-msra/

#MSRA #AcuteMyeloidLeukaemia #AMLMSRA #MSRAHaematology #MSRAFlashcards #MSRAQuiz #PassTheMSRA #FreeMSRA #MSRARevisionNotes #M3APL #HaematologyMSRA

🎙️ Deep Dive: Chronic Lymphocytic Leukaemia (CLL) – Your Shortcut to Mastery 🧬🩸🧠

Feeling buried under CLL revision notes? 📚 Like those lymphocytes are multiplying faster than your brain can keep up? 😅 Don’t worry — we’ve broken it all down for you in this focused, high-yield revision episode, perfect for MSRA prep or clinical practice.

🔍 What You’ll Learn in This Deep Dive:

✅ Definition & Overview
→ CLL = slow-growing B-cell cancer
→ Accumulation of monoclonal, functionally immature lymphocytes
→ Most common leukaemia in adults (accounts for ~25% of cases)

✅ Aetiology & Risk Factors
→ Cause unknown: combination of genetic predisposition (e.g. TP53 mutations) & possible environmental triggers (e.g. pesticides)
→ ⬆️ Risk with age, male sex, family history, and specific gene mutations
→ Average diagnosis age: 70 years

✅ Pathophysiology
→ Clonal expansion of abnormal B-cells
→ Immune dysfunction due to impaired antibody production
→ Bone marrow crowding → ⬇️ RBCs, platelets → anaemia, thrombocytopenia

✅ Presentation & Symptoms
→ Often asymptomatic, found on routine blood test
→ If symptomatic:

• Fatigue, weight loss, night sweats

• Lymphadenopathy (rubbery, symmetrical)

• Splenomegaly, recurrent infections, bruising, petechiae

✅ Investigations
→ 📈 Lymphocytosis ≥5,000/μL for 3+ months
→ Flow cytometry = confirms monoclonal B-cells
→ Blood smear: small lymphocytes + smudge cells 🧫
→ Cytogenetic testing: esp. TP53 mutation
→ Imaging for bulky nodes/splenomegaly (not routine for staging)

✅ Staging (Binet system – Europe/UK)
→ Stage A: <3 lymphoid areas, Hb ≥10g/dL, platelets ≥100
→ Stage B: ≥3 areas, normal Hb/platelets
→ Stage C: Hb <10g/dL and/or platelets <100
🔑 Mnemonics: A = Almost normal, B = Burden of nodes, C = Cytopenias

✅ Management
→ 🎯 Watchful waiting if asymptomatic
→ Start treatment only if symptomatic, progressive disease, or advanced stage
→ Treatment options:

• Targeted therapy: Venetoclax, Ibrutinib, Acalabrutinib

• Chemo-immunotherapy: FCR (Fludarabine, Cyclophosphamide, Rituximab)

• Monoclonal antibodies: Rituximab, Obinutuzumab

• 🌱 Allogeneic stem cell transplant (for high-risk, relapsed cases)

✅ Complications
→ 📉 Immunosuppression → frequent infections
→ 🩸 Autoimmune haemolytic anaemia, ITP
→ ⚠️ Richter’s transformation: CLL → aggressive lymphoma (5–10% risk)
→ ⬆️ Risk of secondary malignancies
→ 🧪 Hypogammaglobulinaemia
→ 💉 Treatment side effects

✅ Prognosis
→ Highly variable: depends on stage, cytogenetics (esp. TP53), response to treatment
→ Many live with CLL for years with minimal impact
→ Survival ranges from 42–82% at 5 years, depending on individual factors

📚 Use These for MSRA Revision:

📝 CLL Revision Notes
https://www.passthemsra.com/topic/chronic-lymphocytic-leukaemia-revision-notes/

🃏 Flashcards
https://www.passthemsra.com/topic/chronic-lymphocytic-leukaemia-flashcards/

📖 Accordion Q&A Notes
https://www.passthemsra.com/topic/chronic-lymphocytic-leukaemia-accordion-qa-notes/

🧠 Rapid Fire Quiz
https://www.passthemsra.com/topic/chronic-lymphocytic-leukaemia-rapid-quiz/

🧪 Practice Quiz
https://www.passthemsra.com/quizzes/chronic-lymphocytic-leukaemia/

📌 Final Thoughts for Reflection:
In slow-growing CLL, the biggest challenge isn’t just the disease — it’s knowing when to start treatment. Balancing risks, side effects, and quality of life is crucial. This deep dive highlights the power of shared decision-making and the need for personalised care in modern haematology. 🩺

#MSRA #ChronicLymphocyticLeukaemia #MSRAFlashcards #MSRAQuiz #MSRAQuestionBank #CLL #HaematologyMSRA #WatchfulWaiting #RichtersTransformation #Leukaemia #MedicalRevision #PassTheMSRA

🎧 MSRA Podcast: Chronic Myeloid Leukaemia (CML) – Fast Facts, High-Yield Review 🎧

It’s time to master CML for your MSRA, with a high-yield deep dive into this classic haematology exam topic. Listen in as we break down everything you need to know for the exam—and for clinical practice.

🧬 Definition:
Chronic Myeloid Leukaemia (CML) is a myeloproliferative neoplasm, marked by uncontrolled proliferation of myeloid white blood cells due to the BCR-ABL1 fusion gene (the Philadelphia chromosome).

⚡ Causes / Risk Factors:

• Philadelphia chromosome (t(9;22)(q34;q11) reciprocal translocation → BCR-ABL1 fusion gene)

• Most cases are sporadic; high-dose ionising radiation is a rare risk factor

• Older age (median diagnosis: 60–72 years), slightly more common in males

🧪 Pathophysiology:

• BCR-ABL1 → abnormal tyrosine kinase protein → drives uncontrolled myeloid cell growth

• Inhibits apoptosis (old cells don’t die) + accelerates cell division

🩺 Clinical Features:

• Often insidious onset—fatigue, weight loss, night sweats, low-grade fever

• Splenomegaly (abdominal fullness, LUQ pain)

• Anaemia (pallor, SOB), easy bruising, recurrent infections

• May be incidentally picked up on a routine FBC

🧠 Phases:

1. Chronic phase (most diagnosed here)

2. Accelerated phase

3. Blast crisis (transformation to acute leukaemia, high mortality)

🔎 Diagnosis:

• FBC: High WCC (all myeloid lines), thrombocytosis

• Peripheral blood film: Immature granulocytes

• Low LAP score

• Bone marrow biopsy: Confirms diagnosis, assesses blast %

• Cytogenetics/FISH/PCR: Philadelphia chromosome and BCR-ABL1

• PCR for ongoing monitoring

🩹 Management:

• First-line: Tyrosine kinase inhibitors (TKIs) — imatinib, nilotinib, dasatinib

• Higher generations or stem cell transplant for resistant/advanced cases

• NICE: Imatinib standard first line, others as alternatives

• Lifelong treatment/monitoring

📈 Prognosis:

• Transformed by TKIs: 5-year survival >90% (was ~33% pre-TKIs)

• Best outcomes if diagnosed in chronic phase, good response to TKI

• Complications: Progression to blast crisis, TKI side effects (cytopenias, GI, cardiovascular), psychological impact

🧠 Memory Aids:

• "FEWBANDS": Fatigue, Easy bruising, Weight loss, Bone pain, Abdominal fullness, Night sweats, Dyspnoea (SOB)

• "9 to 5, switch at 22": Chromosome 9 and 22 swap → Philadelphia chromosome

• 📖 Revision Notes:
https://www.passthemsra.com/topic/chronic-myeloid-leukaemia-revision-notes/

• 🃏 Flashcards:
https://www.passthemsra.com/topic/chronic-myeloid-leukaemia-flashcards/

• ❓ Accordion Q&A Notes:
https://www.passthemsra.com/topic/chronic-myeloid-leukaemia-accordion-qa-notes/

• 🏆 Rapid Fire Quiz:
https://www.passthemsra.com/topic/chronic-myeloid-leukaemia-rapid-quiz/

• 📝 Online Quiz:
https://www.passthemsra.com/quizzes/chronic-myeloid-leukaemia/

#MSRA #CML #ChronicMyeloidLeukaemia #Haematology #MSRARevision #MSRAFlashcards #MSRAQuiz #PassTheMSRA

Exam Pearl:
Always think CML in an older adult with a high WCC, splenomegaly, and fatigue—especially if the Philadelphia chromosome is positive!

🗝️ Key Learning Points🔗 CML Revision Resources for the MSRA

🧬 FREE MSRA PODCAST – Cryoglobulinaemia: Types, Triggers & Top Tips for the MSRA!

In this high-yield episode, we simplify everything you need to know about Cryoglobulinaemia – a tricky but essential Haematology topic for the MSRA. From classification and causes to investigations and complications, this is your fast-track guide to mastering the condition.

🧠 Key Learning Points

📌 Definition
Cryoglobulinaemia = abnormal proteins (cryoglobulins) that precipitate in cold, causing immune complex vasculitis affecting skin, joints, nerves, and kidneys.

📌 Types (Mnemonic: I = Mono, II = Mixed, III = Poly)
Brouet's Classification:

1. Type I – Monoclonal IgM/IgG, linked to myeloma/Waldenström’s

2. Type II – Mixed mono+polyclonal, often with RF activity
    – Linked to Hepatitis C, RA, Sjögren’s, lymphoma

3. Type III – Polyclonal, associated with RA, Sjögren’s
    – Most common type (50%)

📌 Causes & Risk Factors
• >90% have an identifiable cause
• Key trigger: Hepatitis C virus (HCV)
• Others: autoimmune diseases (e.g. SLE, RA), HIV, HBV, lymphoma
• Risks: older age, female sex, chronic infection, autoimmunity

📌 Pathophysiology
Cryoglobulins precipitate in cold, form immune complexes, deposit in small vessels → triggers vasculitis → inflammation & tissue damage (esp. skin, kidneys, nerves)

📌 Clinical Features
🎯 Mnemonic: PWA = Purpura, Weakness, Arthralgia
• Skin: palpable purpura, ulcers, livedo reticularis, gangrene
• Joints: arthralgia, arthritis
• Kidneys: glomerulonephritis, proteinuria
• Nerves: peripheral neuropathy
• Raynaud’s, fatigue, weight loss
• Type I → hyperviscosity (e.g. acrocyanosis, thrombosis)
• Type II/III → classic vasculitis features (skin, kidneys, joints)

📌 Differential Diagnosis
• Autoimmune: SLE, RA, Sjögren’s
• Infective: HCV, HBV, HIV
• Haematological: myeloma, lymphoma, CLL
• Vasculitis: GPA, PAN
• Others: APS, HUS, Goodpasture’s, sarcoidosis, cirrhosis

📌 Investigations
• Cryoglobulin testing (handle warm!)
• HCV serology & viral load
• Rheumatoid factor, low C4, high ESR
• Autoantibodies: ANA, anti-Ro/La
• LFTs, U&Es, urinalysis
• Skin biopsy (vasculitis)
• Serum electrophoresis (monoclonal bands)
• Confirm organ involvement

📌 Management
🎯 Mnemonic: Cool the Cause + Calm Inflammation
• Avoid cold
• Treat underlying cause (e.g. antivirals for HCV)
• Mild symptoms: NSAIDs
• Organ involvement: steroids ± immunosuppressants
• Severe/refractory: plasmapheresis, rituximab

📌 Complications
• Organ damage: kidney failure, neuropathy, gangrene
• Infections (esp. on immunosuppressants)
• Non-Hodgkin lymphoma risk
• Thrombosis, stroke (esp. in Type I)

📌 Prognosis
• Depends on cause + severity
• HCV treatment → possible remission
• Worse if CNS, renal, cardiac involvement or severe fibrosis

📎 More MSRA Resources for Cryoglobulinaemia

📝 Revision Notes:
https://www.passthemsra.com/topic/cryoglobulinaemia-revision-notes/

🧠 Flashcards:
https://www.passthemsra.com/topic/cryoglobulinaemia-flashcards/

💬 Accordion Notes:
https://www.passthemsra.com/topic/cryoglobulinaemia-accordion-qa-notes/

🚀 Rapid Quiz:
https://www.passthemsra.com/topic/cryoglobulinaemia-rapid-quiz/

🎓 Haematology Course:
https://www.passthemsra.com/courses/haematology-for-the-msra/

#MSRA #Cryoglobulinaemia #MSRAHaematology #MSRARevision #MSRAFlashcards #MSRAQandA #MSRAQuiz #PassTheMSRA #FreeMSRA #ImmuneComplexVasculitis #HepatitisC #HaematologyMSRA

🎧 Podcast Episode: Hereditary Angioedema – MSRA Deep DiveIn today’s revision session, we tackle Hereditary Angioedema (HAE) — a rare but high-stakes genetic condition that every MSRA candidate should understand. 📚🩺Let’s break it down simply and memorably.

🧬 What is HAE?Hereditary Angioedema is a rare, autosomal dominant condition caused by C1 esterase inhibitor (C1-INH) deficiency or dysfunction, leading to excessive bradykinin production — which causes severe non-pitting, non-itchy, and urticaria-free swelling in the skin, gut, and airway.

🧠 Mnemonic:
H.A.E. = Hardly Any Enzyme → Huge Amounts of Edema
Type 1 = Low levels of C1-INH → “1 is low”
Type 2 = Dysfunctional C1-INH → “2 doesn’t do”

🚨 Symptoms to Know:• Swelling of face, limbs, genitals• Abdominal attacks: Pain, vomiting, obstruction-like symptoms• Airway swelling: LIFE-THREATENING – priority management• Prodrome: Erythema marginatum (non-itchy, serpiginous rash)• Onset typically in childhood or adolescence• No urticaria, no itching = 🚩 clue it's not allergic angioedema

📋 Differentials to Keep in Mind:
• Allergic angioedema – Usually itchy, with urticaria• Acquired angioedema – Later onset, often in older adults• ACE-inhibitor induced – Common medication trigger• Idiopathic angioedema – Diagnosis of exclusion

🔬 Diagnosis:🧪 C4 level: Typically low during and between attacks🧪 C1-INH antigenic level (how much protein)🧪 C1-INH functional assay (how well it works)🧬 Genetic testing: SERPING1 mutation if needed

🔍 Diagnostic Pathway Summary:• Low C4 + low C1-INH level + low function = Type 1• Low C4 + normal/high C1-INH level but ↓ function = Type 2• Normal C4/C1-INH = consider non-HAE causes or rare types

💊 Acute Management:❗ Standard allergy meds (antihistamines, steroids, adrenaline) do not work✔️ C1-INH concentrate IV (e.g. Berinert, Cinryze)✔️ Icatibant (Firazyr) – bradykinin receptor antagonist✔️ Ecallantide (not widely available in UK)✔️ Fresh frozen plasma – second-line if others unavailable

🛡️ Prophylaxis Options:🩺 Short-term:• Before dental or surgical procedures• C1-INH or FFP (if needed)

🩺 Long-term:• Regular C1-INH infusions (e.g. Cinryze)• Lanadelumab – monoclonal kallikrein inhibitor (SC injection)• Berotralstat – new oral kallikrein inhibitor• Older: Danazol (androgen) – limited due to side effects• Tranexamic acid – weak efficacy but used in children

👶 Special Groups:• Pregnancy: C1-INH concentrate preferred; avoid androgens• Children: C1-INH and tranexamic acid preferred; newer therapies under study• ACE inhibitors + estrogen-containing meds = AVOID

📈 Prognosis & Complications:• If unmanaged, risk of fatal airway obstruction• Abdominal attacks → misdiagnosis, unnecessary surgery• Long-term treatment effects: virilisation (with androgens), reduced QoL• Education, emergency action plans, and regular review are vital for good outcomes

🧠 Quick Recap Mnemonics:• H.A.E. = Hardly Any Enzyme• 1 = Low, 2 = Doesn’t do• 3 A’s = Affected sites → Airway, Abdomen, Appearance (Skin)• Red Flags = Swelling with NO itching, NO urticaria, NO pitting

🧪 Useful Resources for MSRA:

📝 HAE Revision Notes
https://www.passthemsra.com/topic/hereditary-angioedema-revision-notes/

🧠 HAE Flashcards
https://www.passthemsra.com/topic/hereditary-angioedema-flashcards/

❓ Accordion Q&A Notes
https://www.passthemsra.com/topic/hereditary-angioedema-accordion-qa-notes/

🔥 Rapid Quiz
https://www.passthemsra.com/topic/hereditary-angioedema-rapid-quiz/

📢 Final Takeaway:Hereditary Angioedema is not your typical allergic swelling. It’s rare, dangerous, and often misdiagnosed. Recognise the signs. Know your diagnostic tests. And treat with targeted therapy – not antihistamines or steroids. 🧬💉

#MSRA #MSRARevision #HereditaryAngioedema #HAE #MSRAFlashcards #MSRAQuiz #MSRAQandANotes #MedicalPodcast #TheDeepDive #HaematologyMSRA #PasstheMSRA

🎧 Disseminated Intravascular Coagulation (DIC) – MSRA Deep Dive 🩸⚖️

In this high-yield episode, we unpack the chaotic and critical world of DIC – a classic MSRA buzzword and a must-know emergency in clinical practice. Whether it’s sepsis, trauma, or obstetric complications, DIC is always secondary – and always serious.

🔍 What You’ll Learn:

• Definition:
 – DIC = a dangerous imbalance where the body clots and bleeds at the same time
 – Triggered by systemic activation of the coagulation cascade 🧬

• Causes – Use the Mnemonic STUMPLOTS:
 – Sepsis
 – Trauma
 – Uncommon (e.g. Snakebite 🐍)
 – Malignancy
 – Pregnancy (e.g. placental abruption, amniotic fluid embolism)
 – Liver failure
 – Overlooked transfusion reactions
 – Therapies (certain drugs)

• Pathophysiology:
 – Widespread clot formation due to massive thrombin activation
 – Consumption of platelets & clotting factors → bleeding risk
 – Simultaneous fibrinolysis worsens the bleeding

🩺 Clinical Features:

• Acute DIC:
 – Bleeding from ≥3 unrelated sites (e.g. gums, IV lines, hematuria)
 – Bruising, petechiae, purpura, oozing, hematuria
 – Confusion, respiratory distress, multi-organ failure
 – Skin signs: hemorrhagic bullae, acrocyanosis, gangrene

• Chronic DIC:
 – Often more thrombotic than bleeding
 – Presents with DVT, PE, subtle clot-related signs
 – Common in malignancy (especially haematological)

🧪 Investigations:

• 🧬 CBC – ↓ Platelets
• 🧬 Coagulation profile – ↑ PT, ↑ APTT
• 🧬 Fibrinogen – ↓ (but can be normal in early or chronic cases)
• 🧬 D-dimer – ↑↑ (very high)
• 🧬 ISTH DIC Score – Helps quantify severity and diagnose overt DIC

📈 Note: Also consider causes of thrombocytopenia and clotting disorders like TTP, HUS, APL, viral hemorrhagic fevers.

🧰 Management Strategy:

1. 🚨 Treat the underlying cause – always the priority (e.g. antibiotics for sepsis, surgery for trauma)

2. 💧 Supportive care – fluids, monitor organ function

3. 🩸 Blood products if bleeding or before surgery:
    – Platelets if bleeding + <50
    – FFP for prolonged PT/APTT
    – Cryoprecipitate or fibrinogen concentrate if fibrinogen <1–1.5 g/L

4. ⚖️ Heparin – sometimes used if thrombosis dominates in chronic DIC

5. ❌ Avoid antifibrinolytics (e.g. tranexamic acid) in most DIC cases unless extremely selective circumstances

📉 Prognosis:

• Depends on:
 – Speed of intervention
 – Severity of underlying trigger
 – Extent of organ damage

• Complications:
 – Multi-organ failure
 – Catastrophic bleeding
 – Ischemic tissue damage (e.g. limb loss from thrombosis)

💬 Recovery is possible with early recognition + targeted management, but DIC remains a red flag in any critical care setting.

🧠 Memory Aids for the Exam:

• 🔠 STUMPLOTS – for DIC triggers
• 📊 Low platelets + High PT/APTT + High D-dimer + Low fibrinogen = DIC
• 🧪 ISTH Scoring helps standardise diagnosis
• ⚖️ Treat cause first, then correct coagulation imbalances

📝 Revision Resources:

• 📘 Revision Notes:
https://www.passthemsra.com/topic/disseminated-intravascular-coagulation-revision-notes/

• 🃏 Flashcards:
https://www.passthemsra.com/topic/disseminated-intravascular-coagulation-flashcards/

• 📂 Accordion Q&A Notes:
https://www.passthemsra.com/topic/disseminated-intravascular-coagulation-accordion-qa-notes/

• 🎯 Rapid Fire Quiz:
https://www.passthemsra.com/topic/disseminated-intravascular-coagulation-rapid-quiz/

• 🧪 Practice Quiz:
https://www.passthemsra.com/quizzes/disseminated-intravascular-coagulation/

🌐 Main Sites:
https://www.passthemsra.com
https://www.freemsra.com

🤔 Final Thought:
DIC is the canary in the coal mine. It’s a signal that the body is overwhelmed – a reaction, not a diagnosis. Spotting it early can mean the difference between life and death. Are we doing enough to identify it in time across busy wards and ICUs?

#MSRA #DIC #DisseminatedIntravascularCoagulation #MSRAHaematology #MSRAQuestionBank #MSRAFlashcards #MSRAAccordions #PassTheMSRA #FreeMSRA #AcuteMedicine #CriticalCare #UKMLA #MSRARevision

🎙️ Deep Dive: Factor V Leiden – The Sticky Switch of Clotting 🩸🧬🛑

Welcome to another fast-paced revision episode, perfect for MSRA prep and clinical understanding! Today, we’re diving into Factor V Leiden, the most common inherited thrombophilia — the genetic twist that makes blood just a bit too eager to clot. 🧠💥

🔍 What you’ll learn in this episode:

✅ Definition
→ Factor V Leiden is a genetic mutation in the F5 gene, making clotting factor V resistant to inactivation by activated protein C (APC).
→ Leads to a hypercoagulable state, increasing the risk of venous thromboembolism (VTE).

✅ Genetics
→ Autosomal dominant inheritance 🧬
→ Only one copy needed to increase clot risk (heterozygous = 3–5x risk)
→ Homozygous carriers have up to 8x or higher risk

✅ Pathophysiology
→ Normally, APC inactivates factor V to regulate clotting
→ In Factor V Leiden, this “off switch” doesn’t work well – “sticky switch” analogy
→ Results in prolonged thrombin generation, more fibrin = increased clot risk

✅ Symptoms & Presentation
→ Many are asymptomatic!
→ If symptomatic: classic DVT (leg swelling, pain, redness) or PE (SOB, chest pain, haemoptysis)
→ May also be found after recurrent miscarriage or unprovoked clots in young patients

✅ Differentials
→ Other inherited thrombophilias:

• Protein C deficiency

• Protein S deficiency

• Antithrombin deficiency

• Prothrombin G20210A mutation
  → Plus acquired risks: immobility, surgery, pregnancy, HRT, malignancy, autoimmune disease

✅ Epidemiology
→ Present in ~5% of UK Caucasians
→ Rare in Black African, East Asian, Indigenous Australian, Native American populations
→ May have had evolutionary benefits (e.g. reduced postpartum bleeding) 🧬🤔

✅ Investigations
→ Activated Protein C resistance assay (initial screen)
→ DNA testing for F5 mutation (gold standard)
→ Clot imaging if acute DVT/PE suspected:

• Doppler ultrasound

• CT Pulmonary Angiography (CTPA)

✅ Management
→ If clot occurs: treat with DOACs or warfarin, duration depends on whether it was provoked
→ If no clot: usually no routine anticoagulation
→ Focus on lifestyle: stay active, healthy weight, avoid long immobility 🧘‍♂️
→ Temporary prophylaxis (e.g. LMWH) in high-risk situations like surgery, pregnancy
→ Caution with oestrogen-based contraception 💊
→ Pregnancy care: LMWH may be used if high-risk or previous VTE

✅ Complications
→ Recurrent VTE (DVT/PE)
→ Bleeding risks from anticoagulants
→ Risk increases during surgery, immobility, and pregnancy
→ Complex links to recurrent miscarriage, possibly related to placental clotting

✅ Interesting Twist 🤯
→ Some potential protective effects:

• Less menstrual bleeding

• Lower risk of intracranial haemorrhage

• Possible improved outcomes in sepsis or ARDS
  → A classic example of a genetic paradox

📚 Your MSRA Revision Toolkit for Factor V Leiden:

📝 Revision Notes:
https://www.passthemsra.com/topic/factor-v-leiden-deficiency-revision-notes/

🃏 Flashcards:
https://www.passthemsra.com/topic/factor-v-leiden-deficiency-flashcards/

📖 Accordion Q&A Notes:
https://www.passthemsra.com/topic/factor-v-leiden-deficiency-accordion-qa-notes/

🧠 Rapid Quiz:
https://www.passthemsra.com/topic/factor-v-leiden-deficiency-rapid-quiz/

🧪 Quiz Link:
https://www.passthemsra.com/quizzes/factor-v-leiden/

📌 Key Takeaway
🧬 Factor V Leiden = sticky clotting switch
🔎 Think: inherited, asymptomatic or VTE presentations, diagnosed by APC resistance + DNA testing
💊 Manage based on clot risk, not just gene carriage
🧠 Remember the “sticky switch” analogy – and keep this high-yield thrombophilia firmly in mind for MSRA!

#MSRA #FactorVLeiden #Thrombophilia #MSRARevision #MSRAFlashcards #VTE #HaematologyMSRA #ClottingDisorders #PassTheMSRA #Haematology #VenousThromboembolism #StickySwitch

🎧 MSRA Podcast: Deep Vein Thrombosis (DVT) – Rapid Review Edition 🎧

Why does a swollen, painful leg worry every clinician? Because it could be DVT—a classic MSRA topic and a major cause of preventable death. In this episode, we smash through the essentials you need for the exam and real life: causes, risk factors, how to spot it, investigate it, and treat it—plus classic pitfalls and memory aids.

🔬 Definition:
Deep Vein Thrombosis (DVT) = formation of a blood clot in a deep vein, usually in the legs. Can cause local symptoms or break off to cause a pulmonary embolism (PE)—potentially fatal.

⚡ Causes (Virchow’s Triad):

1. Venous stasis (immobility: long travel, bed rest, hospitalisation)

2. Hypercoagulability (cancer, pregnancy, OCP/HRT, inherited thrombophilia)

3. Endothelial injury (surgery, trauma, inflammation)

🚩 Risk Factors:
• Recent surgery/trauma
• Immobility/long-haul travel
• Cancer
• Increasing age
• Obesity
• Pregnancy/postpartum
• OCP/HRT
• Previous DVT/PE
• Inherited thrombophilia
• Chronic diseases (e.g., IBD)

🩺 Clinical Features:
• Usually unilateral leg swelling, pain, redness, warmth
• Pitting oedema
• Calf tenderness
• Sometimes asymptomatic!
• Complication = PE (sudden chest pain, dyspnoea)

🔎 Differentials:

• Cellulitis

• Superficial thrombophlebitis

• Ruptured Baker’s cyst

• Muscle tear/haematoma

• Lymphoedema

📊 Diagnosis (NICE Pathway):
• Assess risk with 2-level DVT Wells Score
• If likely: urgent compression ultrasound
• If unlikely: D-dimer
• D-dimer: Good to rule out DVT in low-risk, but not specific
• Age-adjusted D-dimer for patients over 50
• Further imaging if initial tests are inconclusive

💊 Management:

• Anticoagulation (first-line = DOACs: apixaban, rivaroxaban)

• LMWH/warfarin if DOACs contraindicated

• Duration: usually 3 months (provoked), 6 months (unprovoked/cancer)

• Leg elevation, compression stockings (select cases)

• Address modifiable risk factors

🚨 Complications:

• Pulmonary embolism (PE): Life-threatening!

• Post-thrombotic syndrome: Chronic pain, swelling, ulcers

• Recurrence: Especially if unprovoked or persistent risk factors

• 📖 Revision Notes:
https://www.passthemsra.com/topic/deep-vein-thrombosis-revision-notes/

• 🃏 Flashcards:
https://www.passthemsra.com/topic/deep-vein-thrombosis-flashcards/

• ❓ Accordion Q&A Notes:
https://www.passthemsra.com/topic/deep-vein-thrombosis-accordion-qa-notes/

• 🏆 Rapid Fire Quiz:
https://www.passthemsra.com/topic/deep-vein-thrombosis-rapid-quiz/

• 📝 Online Quiz:
https://www.passthemsra.com/quizzes/deep-vein-thrombosis/

#MSRA #DVT #DeepVeinThrombosis #VTE #Haematology #MSRARevision #MSRAFlashcards #MSRAQuiz #PassTheMSRA

MSRA Exam Pearl:
Always assess for PE risk in every patient with DVT—unexplained shortness of breath or chest pain could be a silent embolism!

🗝️ Key Learning Points🔗 Deep Vein Thrombosis Resources for the MSRA